Evidence map›Paper›PMID 38500112›Full record

Trial reportBMC medical education2024

Development and validation of a cadaveric porcine Pseudotumor model for Oral Cancer biopsy and resection training.

Claire Melchior, Peter Isfort, Till Braunschweig, Max Witjes, Vincent Van den Bosch, Ashkan Rashad, Jan Egger, Matías de la Fuente, Rainer Röhrig, Frank Hölzle and 1 more

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in BMC medical education, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Claire MelchiorDepartment of Oral and Maxillofacial Surgery, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Germany.ORCID http://orcid.org/0000-0002-5612-4796
Peter IsfortDepartment of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, 52074, Aachen, Germany.ORCID http://orcid.org/0000-0002-0978-8995
Till BraunschweigInstitute of Pathology, RWTH Aachen University, 52074, Aachen, Germany.ORCID http://orcid.org/0000-0001-9166-2912
Max WitjesDepartment of Oral and Maxillofacial Surgery, UMCG Groningen, 9713, GZ, Groningen, The Netherlands.ORCID http://orcid.org/0000-0002-4135-3246
Vincent Van den BoschDepartment of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, 52074, Aachen, Germany.ORCID http://orcid.org/0000-0003-4489-6446
Ashkan RashadDepartment of Oral and Maxillofacial Surgery, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Germany.ORCID http://orcid.org/0000-0003-3743-8658
Jan EggerCancer Research Center Cologne Essen (CCCE), University Medicine Essen (AöR), 45147, Essen, Germany.ORCID http://orcid.org/0000-0002-5225-1982
Matías de la FuenteChair of Medical Engineering, RWTH Aachen University, 52074, Aachen, Germany.ORCID http://orcid.org/0000-0002-7911-155X
Rainer RöhrigInstitute of Medical Informatics, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Germany.ORCID http://orcid.org/0000-0002-0032-5118
Frank HölzleDepartment of Oral and Maxillofacial Surgery, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Germany.ORCID http://orcid.org/0000-0002-2298-3517
Behrus PuladiDepartment of Oral and Maxillofacial Surgery, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Germany. bpuladi@ukaachen.de.ORCID http://orcid.org/0000-0001-5909-6105
RWTH Aachen University · DEDialyse Centrum Groningen · NLEssen University Hospital · DELudwig-Maximilians-Universität München · DEUniversitätsklinikum Aachen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe gold standard of oral cancer (OC) treatment is diagnostic confirmation by biopsy followed by surgical treatment. However, studies have shown that dentists have difficulty performing biopsies, dental students lack knowledge about OC, and surgeons do not always maintain a safe margin during tumor resection. To address this, biopsies and resections could be trained under realistic conditions outside the patient. The aim of this study was to develop and to validate a porcine pseudotumor model of the tongue.

methodsAn interdisciplinary team reflecting various specialties involved in the oncological treatment of head and neck oncology developed a porcine pseudotumor model of the tongue in which biopsies and resections can be practiced. The refined model was validated in a final trial of 10 participants who each resected four pseudotumors on a tongue, resulting in a total of 40 resected pseudotumors. The participants (7 residents and 3 specialists) had an experience in OC treatment ranging from 0.5 to 27 years. Resection margins (minimum and maximum) were assessed macroscopically and compared beside self-assessed margins and resection time between residents and specialists. Furthermore, the model was evaluated using Likert-type questions on haptic and radiological fidelity, its usefulness as a training model, as well as its imageability using CT and ultrasound.

resultsThe model haptically resembles OC (3.0 ± 0.5; 4-point Likert scale), can be visualized with medical imaging and macroscopically evaluated immediately after resection providing feedback. Although, participants (3.2 ± 0.4) tended to agree that they had resected the pseudotumor with an ideal safety margin (10 mm), the mean minimum resection margin was insufficient at 4.2 ± 1.2 mm (mean ± SD), comparable to reported margins in literature. Simultaneously, a maximum resection margin of 18.4 ± 6.1 mm was measured, indicating partial over-resection. Although specialists were faster at resection (p < 0.001), this had no effect on margins (p = 0.114). Overall, the model was well received by the participants, and they could see it being implemented in training (3.7 ± 0.5).

conclusionThe model, which is cost-effective, cryopreservable, and provides a risk-free training environment, is ideal for training in OC biopsy and resection and could be incorporated into dental, medical, or oncologic surgery curricula. Future studies should evaluate the long-term training effects using this model and its potential impact on improving patient outcomes.

Indexed as

Margins of ExcisionMouth NeoplasmsAnimalsBiopsyCadaverHeadHumansSwineBiopsyEducation, dentalMargins of excisionModels, anatomicalMouth neoplasmsOral surgical proceduresSimulation trainingSurgical oncology

Identifiers

PMID38500112
PMCPMC10949621
OpenAlexW4392928126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.